Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 4/2012

01-10-2012 | Maternal-Fetal Medicine

Pregnancy outcomes in women with Ebstein’s anomaly

Authors: WeiXiu Zhao, Hua Liu, Ran Feng, JianHua Lin

Published in: Archives of Gynecology and Obstetrics | Issue 4/2012

Login to get access

Abstract

Objectives

To evaluate whether women with Ebstein’s anomaly can tolerate pregnancy and whether the perinatal outcomes are influenced by the severity of Ebstein’s anomaly.

Methods

Data of four women with Ebstein’s anomaly delivered in our unit were collected and analyzed retrospectively.

Results

(1) Two women with Ebstein’s anomaly had uneventful pregnancies, cesarean section and puerperium. (2) The patient with the most serious Ebstein’s anomaly (with central cyanosis and clubbing) had an episode of paroxysmal ventricular tachycardia and spontaneous cardioversion to sinus rhythm on day 4 postpartum. She developed intracerebral hemorrhage on day 25 postpartum. (3) One of them suffered from atrial flutter on 38 + 3 weeks of gestation which was restored to sinus rhythm after being treated with verapamil and remained stable afterward. (4) All neonatal birth weights were more than 2,500 g, and all neonatal Apgar scores were 10 at 1 min. (5) The gestational age at delivery of our cases was from week 36 + 4 to week 38 + 4. The mean duration of follow-up was 56 days postpartum.

Conclusions

(1) The clinical features of pregnant women with Ebstein’s anomaly vary. They might have good perinatal outcomes when given appropriate treatment. (2) Those with cyanosis should be given more attention, as they can have more complications during pregnancy, delivery and puerperium. (3) All women with Ebstein’s anomaly should be offered fetal echocardiography during pregnancy. (4) Vaginal delivery is advised for most cases with Ebstein’s anomaly.
Literature
1.
go back to reference Donnelly JE, Brown JM, Radford DJ (1991) Pregnancy outcome and Ebstein’s anomaly. Br Heart J 66:368–371PubMedCrossRef Donnelly JE, Brown JM, Radford DJ (1991) Pregnancy outcome and Ebstein’s anomaly. Br Heart J 66:368–371PubMedCrossRef
2.
go back to reference Paranon S, Acar P (2008) Ebstein’s anomaly of the tricuspid valve: from fetus to adult. Heart 94:237–243PubMedCrossRef Paranon S, Acar P (2008) Ebstein’s anomaly of the tricuspid valve: from fetus to adult. Heart 94:237–243PubMedCrossRef
3.
go back to reference Littler WA (1970) Successful pregnancy in a patient with Ebstein’s anomaly. Br Heart J 32:711–713PubMedCrossRef Littler WA (1970) Successful pregnancy in a patient with Ebstein’s anomaly. Br Heart J 32:711–713PubMedCrossRef
4.
go back to reference Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, Mayet J, Francis DP (2007) Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93(4):476–482PubMedCrossRef Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, Mayet J, Francis DP (2007) Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93(4):476–482PubMedCrossRef
5.
go back to reference Giuliani ER, Fuster V, Brandenburg RO, Mair DD (1979) Ebstein’s anomaly: the clinical features and natural history of Ebstein’s anomaly of the tricuspid valve. Mayo Clin Proc 54:163–173PubMed Giuliani ER, Fuster V, Brandenburg RO, Mair DD (1979) Ebstein’s anomaly: the clinical features and natural history of Ebstein’s anomaly of the tricuspid valve. Mayo Clin Proc 54:163–173PubMed
7.
go back to reference Choi YH, Park JH, Choe YH, Yoo SJ (1994) MR imaging of Ebstein’s anomaly of the tricuspid valve. Am J Roentgenol 163:539–543 Choi YH, Park JH, Choe YH, Yoo SJ (1994) MR imaging of Ebstein’s anomaly of the tricuspid valve. Am J Roentgenol 163:539–543
8.
go back to reference Sommer RJ, Hijazi ZM, Rhodes JF (2008) Pathophysiology of congenital heart disease in the adult: part III: complex congenital heart disease. Circulation 117(10):1340–1350PubMedCrossRef Sommer RJ, Hijazi ZM, Rhodes JF (2008) Pathophysiology of congenital heart disease in the adult: part III: complex congenital heart disease. Circulation 117(10):1340–1350PubMedCrossRef
10.
go back to reference Groves ER, Groves JB (1995) Epidural analgesia for labour in a patient with Ebstein’s anomaly. Can J Anaesth 42(1):77–79PubMedCrossRef Groves ER, Groves JB (1995) Epidural analgesia for labour in a patient with Ebstein’s anomaly. Can J Anaesth 42(1):77–79PubMedCrossRef
11.
go back to reference Shina A, Seward JB, Edwards WD, Hagler DJ, Tajik AJ (1984) Two-dimensional echocardiographic spectrum of Ebstein’s anomaly: detailed anatomic assessment. J Am Col Cardiol 3:356–370CrossRef Shina A, Seward JB, Edwards WD, Hagler DJ, Tajik AJ (1984) Two-dimensional echocardiographic spectrum of Ebstein’s anomaly: detailed anatomic assessment. J Am Col Cardiol 3:356–370CrossRef
12.
go back to reference Chopra S, Suri V, Aggarwal N, Rohilla M, Vijayvergiya R, Keepanasseril A (2010) Ebstein’s anomaly in pregnancy: maternal and neonatal outcomes. J Obstet Gynaecol Res 36(2):278–283PubMedCrossRef Chopra S, Suri V, Aggarwal N, Rohilla M, Vijayvergiya R, Keepanasseril A (2010) Ebstein’s anomaly in pregnancy: maternal and neonatal outcomes. J Obstet Gynaecol Res 36(2):278–283PubMedCrossRef
13.
go back to reference Macfarlane AJ, Moise S, Smith D (2007) Caesarean section using total intravenous anaesthesia in a patient with Ebstein’s anomaly complicated by supraventricular tachycardia. Int J Obstet Anesth 16:155–159PubMedCrossRef Macfarlane AJ, Moise S, Smith D (2007) Caesarean section using total intravenous anaesthesia in a patient with Ebstein’s anomaly complicated by supraventricular tachycardia. Int J Obstet Anesth 16:155–159PubMedCrossRef
14.
go back to reference Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R (2005) Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45:86–91PubMed Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R (2005) Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45:86–91PubMed
15.
go back to reference Connolly HM, Warnes CA (1994) Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol 23:1194–1198PubMedCrossRef Connolly HM, Warnes CA (1994) Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol 23:1194–1198PubMedCrossRef
16.
17.
go back to reference Abbas AE, Lester SJ, Connolly H (2005) Pregnancy and the cardiovascular system. Int J Cardiol 98(2):179–189PubMedCrossRef Abbas AE, Lester SJ, Connolly H (2005) Pregnancy and the cardiovascular system. Int J Cardiol 98(2):179–189PubMedCrossRef
18.
go back to reference Draisci G, Valente A, Suppa E, Frassanito L, Pinto R, Meo F, De Sole P, Bossù E, Zanfini BA (2008) Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth 17(2):130–136PubMedCrossRef Draisci G, Valente A, Suppa E, Frassanito L, Pinto R, Meo F, De Sole P, Bossù E, Zanfini BA (2008) Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth 17(2):130–136PubMedCrossRef
19.
go back to reference Maghsoudloo M, Eftekhar N, Noyan Ashraf MA, Khan ZH, Peiravy Sereshkeh H (2011) Does intravenous fentanyl affect Apgar scores and umbilical vessel blood gas parameters in cesarean section under general anesthesia? Acta Med Iran 49(8):517–522PubMed Maghsoudloo M, Eftekhar N, Noyan Ashraf MA, Khan ZH, Peiravy Sereshkeh H (2011) Does intravenous fentanyl affect Apgar scores and umbilical vessel blood gas parameters in cesarean section under general anesthesia? Acta Med Iran 49(8):517–522PubMed
20.
go back to reference European Society of Gynecology; Association for European Paediatric Cardiology; German Society for Gender Medicine; Authors/Task Force Members, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L; ESC Committee for Practice Guidelines, Bax J, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Baumgartner H, Deaton C, Aguiar C, Al-Attar N, Garcia AA, Antoniou A, Coman I, Elkayam U, Gomez-Sanchez MA, Gotcheva N, Hilfiker-Kleiner D, Kiss RG, Kitsiou A, Konings KT, Lip GY, Manolis A, Mebaaza A, Mintale I, Morice MC, Mulder BJ, Pasquet A, Price S, Priori SG, Salvador MJ, Shotan A, Silversides CK, Skouby SO, Stein JI, Tornos P, Vejlstrup N, Walker F, Warnes C (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197 European Society of Gynecology; Association for European Paediatric Cardiology; German Society for Gender Medicine; Authors/Task Force Members, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L; ESC Committee for Practice Guidelines, Bax J, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Baumgartner H, Deaton C, Aguiar C, Al-Attar N, Garcia AA, Antoniou A, Coman I, Elkayam U, Gomez-Sanchez MA, Gotcheva N, Hilfiker-Kleiner D, Kiss RG, Kitsiou A, Konings KT, Lip GY, Manolis A, Mebaaza A, Mintale I, Morice MC, Mulder BJ, Pasquet A, Price S, Priori SG, Salvador MJ, Shotan A, Silversides CK, Skouby SO, Stein JI, Tornos P, Vejlstrup N, Walker F, Warnes C (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197
21.
go back to reference Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24(8):761–781 Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24(8):761–781
22.
go back to reference Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900PubMedCrossRef Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900PubMedCrossRef
Metadata
Title
Pregnancy outcomes in women with Ebstein’s anomaly
Authors
WeiXiu Zhao
Hua Liu
Ran Feng
JianHua Lin
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 4/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2386-3

Other articles of this Issue 4/2012

Archives of Gynecology and Obstetrics 4/2012 Go to the issue